首页> 美国卫生研究院文献>Oxidative Medicine and Cellular Longevity >Impaired Mitochondrial Fusion and Oxidative Phosphorylation Triggered by High Glucose Is Mediated by Tom22 in Endothelial Cells
【2h】

Impaired Mitochondrial Fusion and Oxidative Phosphorylation Triggered by High Glucose Is Mediated by Tom22 in Endothelial Cells

机译:受损的线粒体融合和高磷酸触发的氧化磷酸化介导的内皮细胞中的Tom22。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Much evidence demonstrates that mitochondrial dysfunction plays a crucial role in the pathogenesis of vascular complications of diabetes. However, the signaling pathways through which hyperglycemia leads to mitochondrial dysfunction of endothelial cells are not fully understood. Here, we treated human umbilical vein endothelial cells (HUVECs) with high glucose and examined the role of translocase of mitochondrial outer membrane (Tom) 22 on mitochondrial dynamics and cellular function. Impaired Tom22 expression and protein expression of oxidative phosphorylation (OXPHOS) as well as decreased mitochondrial fusion were observed in HUVECs treated with high glucose. The deletion of Tom22 resulted in reduced mitochondrial fusion and ATP production and increased apoptosis in HUVECs. The overexpression of Tom22 restored the balance of mitochondrial dynamics and OXPHOS disrupted by high glucose. Importantly, we found that Tom22 modulates mitochondrial dynamics and OXPHOS by interacting with mitofusin (Mfn) 1. Taken together, our findings demonstrate for the first time that Tom22 is a novel regulator of both mitochondrial dynamics and bioenergetic function and contributes to cell survival following high-glucose exposure.
机译:许多证据表明,线粒体功能障碍在糖尿病血管并发症的发病机理中起着至关重要的作用。然而,高血糖导致内皮细胞线粒体功能障碍的信号途径尚不完全清楚。在这里,我们用高葡萄糖治疗人脐静脉内皮细胞(HUVECs),并检查了线粒体外膜(Tom)22的转位酶对线粒体动力学和细胞功能的作用。在高糖处理的HUVEC中,氧化磷酸化(OXPHOS)的Tom22表达和蛋白质表达受损,以及线粒体融合减少。 Tom22的缺失导致线粒体融合和ATP产生减少,HUVECs凋亡增加。 Tom22的过表达恢复了线粒体动力学和高糖破坏的OXPHOS的平衡。重要的是,我们发现Tom22通过与线粒体蛋白(Mfn)1相互作用来调节线粒体动力学和OXPHOS。综上所述,我们的发现首次证明,Tom22是线粒体动力学和生物能功能的新型调节剂,并且在高剂量下有助于细胞存活。 -葡萄糖暴露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号